| 000 | 00990 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518044619.0 | ||
| 264 | 0 | _c20190709 | |
| 008 | 201907s 0 0 rus d | ||
| 022 | _a0022-9040 | ||
| 024 | 7 |
_a10.18087/cardio.2522 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDyadyk, A I | |
| 245 | 0 | 0 |
_a[Statin-associated muscle symptoms: epidemiology, risk factors, mechanisms and treatment]. _h[electronic resource] |
| 260 |
_bKardiologiia _cJun 2019 |
||
| 300 |
_a4-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHypolipidemic Agents |
| 650 | 0 | 4 | _aMuscle, Skeletal |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aKugler, T E | |
| 700 | 1 | _aZborowskyy, S R | |
| 700 | 1 | _aSuliman, Yu V | |
| 773 | 0 |
_tKardiologiia _gvol. 59 _gno. 5S _gp. 4-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18087/cardio.2522 _zAvailable from publisher's website |
| 999 |
_c29819781 _d29819781 |
||